Alnylam Pharmaceuticals
ALNY
#550
Rank
C$52.41 B
Marketcap
$406.65
Share price
-0.40%
Change (1 day)
80.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company